In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct
2017
Overexpression of human epidermal growth factor receptor 3 (HER3) is involved in resistance to several therapies for malignant tumours. Currently, several anti-HER3 monoclonal antibodies are under ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
51
References
14
Citations
NaN
KQI